By Emeritus Professor John Whitelock

Conference Papers

Kennett E; Chuang CY; Degendorfer G; Rees MD; Hammer A; Malle E; Whitelock JM; Davies MJ, 2010, 'Extracellular Matrix Proteoglycans are a Major Target for Peroxynitrite in the Artery Wall', in FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE INC, FL, Orlando, pp. S113 - S113, presented at 17th Annual Meeting of the Society-for-Free-Radical-Biology-Medicine /15th Biennial Meeting of the Society-for-Free-Radical-Research-International, FL, Orlando, 17 November 2010 - 21 November 2010, http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.302

Kennett EC; Rees MD; Whitelock JM; Davies MJ, 2009, 'Peroxynitrite Modifies the Structure and Function of the Extracellular Matrix Proteoglycan Perlecan by Reaction with both the Protein Core and the Heparan Sulfate Chains', in FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE INC, CA, San Francisco, pp. S73 - S74, presented at 16th Annual Meeting of the Society-for-Free-Radical-Biology-and-Medicine, CA, San Francisco, 18 November 2009 - 22 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271988500207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Melrose C; Knox SM; Iozzo R; Whitelock J; Chuang CY, 2009, 'The role of heparan sulfate on chondrocyte perlecan - to proliferate or not?', in International Journal of Experimental Pathology, Blackwell Publishing Ltd, Oxford, England, pp. A102 - A103, presented at Annual General Meeting of the British-Society-for-Matrix-Biology, York Univ, York, ENGLAND, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264345300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Rees M; Chuang CY; Whitelock J; Davies MJ, 2007, 'Oxidative degradation of perlecan, a key matrix proteoglycan, by myclopcroxidase-derived oxidants and its consequences', in Free Radical Research, Taylor & Francis Ltd, Abingdon, England, pp. S49 - S49, presented at SFRR-Europe, Vilamoura, PORTUGAL, 10 October 2007 - 13 October 2007, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000252296300182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Conference Proceedings (Editor of)

Chau N; Poole-Warren LA; Whitelock J, (eds.), 2004, '7th World Biomaterials Congress', Sydney, presented at 7th World Biomaterials Congress, Sydney, 17 May 2004 - 21 May 2004

Whitelock J; Karlsson N; Melrose J; Knox SM; Schulz B; Robinson L; Packer N; Last K; Fosang A, (eds.), 2004, 'Gordon Conference on Proteoglycans', New Hampshire, USA, presented at Gordon Conference on Proteoglycans, New Hampshire, USA

Whitelock J; Karlsson N; Melrose J; Knox SM; Schulz B; Packer N; Last K; Fosang A, (eds.), 2004, 'Matrix Biology Society of Australia and New Zealand', Rottnest Island, WA, presented at Matrix Biology Society of Australia and New Zealand, Rottnest Island, WA

Melrose J; Smith SA; Ghosh P; Whitelock J, (eds.), 2003, 'Orthopedic Research Society', Orleans, USA, presented at Orthopedic Research Society, Orleans, USA

Whitelock J; Schulz B; Knox SM; Melrose J; Packer N, (eds.), 2003, 'Osteoarthritis Research Society International', Berlin, Germany, presented at Osteoarthritis Research Society International, Berlin, Germany

Conference Posters

Nilasaroya A; Poole-Warren LA; Whitelock J; Martens P, 2008, 'Structural and Functional Characterisation of Poly (Vinyl Alcohol) and Heparin Copolymers', Canberra, Australia, presented at 18th Annual Australasian Society for Biomaterials and Tissue Engineering Conference, Canberra, Australia, 22 February 2008 - 22 February 2008

Conference Presentations

Young C; Cheng J; Whitelock J; Martens P; Poole-Warren L, 2011, 'Islet matrix identification for use in biosynthetic microencapsulation'

Martens P; Nilasaroya A; Whitelock J; Poole-Warren LA, 2009, 'Biosynthetic Hydrogel Composite Materials: Maintaining Network Structure and Improving Biological Performance', presented at Biomaterials Asia, Hong Kong, -

Martens P; Nilasaroya A; Reeves A; Kundu ; Kundu S; Whitelock J; Poole-Warren LA, 2009, 'Poly (Vinyl Alcohol) Hydrogels: Improving Biological Performance', presented at European Society for Biomaterials 2009, Lausanne, Switzerland

Nilasaroya A; Poole-Warren LA; Whitelock J; Martens P, 2009, 'Poly(Vinyl Aochol)-Heparin Hydrogels: Growth Factor Activation and Degradation', presented at BITE&RM and Australasian Society for Biomaterials and Tissue Engineering 2009, Sydney, Australia

Nilasaroya A; Poole-Warren LA; Whitelock J; Martens P, 2008, 'Structural and Functional Characterization of Poly (Vinyl Alcohol) and Heparin Copolymers', Vol. 2, pp. 872, presented at World Biomaterials Congress, Amsterdam, Netherlands

Nilasaroya A; Poole-Warren LA; Whitelock J; Martens P, 2007, 'Characterisation of Poly(Vinyl Alcohol) and Heparin Hydrogels Formed from Methacrylated Macromers', presented at Australasian Society for Biomaterials and Tissue Engineering 2007, Mt Eliza, Australia, -

Martens P; Whitelock J; Poole-Warren LA, 2007, 'Redox Initiated Hydrogels for Tissue Engineering Applications', presented at Australasian Society for Biomaterials and Tissue Engineering 2007, Mt Eliza, Australia, -

Poole-Warren LA; Nilasaroya A; Grant M; Whitelock J; Martens P, 2007, 'Biosynthetic Hydrogels as injectable soft-tissue engineering scaffolds', presented at TERMIS-AP, Tokyo, Japan

Martens P; Whitelock J; Poole-Warren LA, 2007, 'Characterisation of Redox Polymerised Poly (Vinyl Alcohol) Hydrogels', presented at International Congress on Biohydrogels, Viareggio, Italy

Whitelock J; Davies N; Jung M; Nilasaroya A; Chuang C; Neilsen N; Martens P, 2007, 'Heparan Sulfate as a Biosignalling Molecule for Tissue Engineering Applications', presented at TERMIS-AP, Tokyo, Japan

Nilasaroya A; Poole-Warren LA; Whitelock J; Martens P, 2007, 'Network Formation of Poly(Vinyl Alcohol)-Heparin Hydrogels', presented at International Congress on Biohydrogels, Viareggio, Italy

Conference Abstracts

Johnson BB; Holmes TL; Thompson JL; Lord M; Denning C; Whitelock J; Merry CLR; Smith J, 2021, 'A CRISPR/Cas9 in vitro human-induced pluripotent stem cell (hiPSC) model to investigate the role of perlecan in cardiovascular fibrotic disease', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, Vol. 102, pp. 126 - 127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630872200029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith J; Merry C; Lord M; Denning C; Whitelock J, 2018, 'Developing an in vitro human induced pluripotent stem cell (hiPSC) model using CRISPR/Cas9 to investigate the role of perlecan in fibrosis', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, ENGLAND, Manchester, Vol. 99, pp. A20 - A21, presented at Matrix Biology Europe Meeting, ENGLAND, Manchester, 21 July 2018 - 24 July 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459467900041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Elgundi Z; Freelander A; Bean P; Whitelock J; Lord M, 2018, 'Investigating the roles of perlecan using antibodies with unique epitopes', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, ENGLAND, Manchester, Vol. 99, pp. A23 - A23, presented at Matrix Biology Europe Meeting, ENGLAND, Manchester, 21 July 2018 - 24 July 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459467900046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thompson J; Ashworth J; Whitelock J; Merry C, 2017, 'Modelling the brain tumour microenvironment', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, ENGLAND, Univ Oxford, Oxford, Vol. 98, pp. A22 - A22, presented at Spring Meeting of the British-Society-for-Matrix-Biology (BSMB), ENGLAND, Univ Oxford, Oxford, 03 April 2017 - 04 April 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408620000047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS, 2016, 'Domain V of Perlecan Covalently Immobilized on Silk Biomaterials Modulates Endothelial Cell and Platelet Interactions for Vascular Applications', in TISSUE ENGINEERING PART A, MARY ANN LIEBERT, INC, CA, San Diego, Vol. 22, pp. S20 - S21, presented at TERMIS - Americas Conference and Exhibition, CA, San Diego, 11 December 2016 - 14 December 2016

Tang F; Lau K; Kondyurin A; Lord MS; Whitelock JM; Bilek MM; Rnjak-Kovacina J, 2016, 'Plasma Immersion Ion Implantation Treatment of Silk Biomaterials Enhances Biological Function', in TISSUE ENGINEERING PART A, MARY ANN LIEBERT, INC, San Diego, Vol. 22, pp. S129 - S129, presented at TISSUE ENGINEERING PART A, San Diego, 11 December 2016 - 14 December 2016

Farrugia BL; Whitelock J; Lord M, 2016, 'CHITOSAN SULPHATE: ENGINEERING A BIOMIMETIC GROWTH FACTOR DELIVERY SYSTEM', in Wound Repair and Regeneration, Wiley, Melbourne, Australia, Vol. 24, pp. A13 - A30, presented at Joint meeting of the Australasian Wound and Tissue Repair Society (AWTRS) and the Molecular & Experimental Pathology Society of Australasia (MEPSA), Melbourne, Australia, 07 November 2016 - 09 November 2016, http://dx.doi.org/10.1111/wrr.12489

Farrugia BL; Whitelock J; LORD M, 2016, 'The inflammatory response to implanted materials, fibrous capsule characterisation', in Front. Bioeng. Biotechnol., presented at 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016., http://dx.doi.org/10.3389/conf.FBIOE.2016.01.00994

Farrugia BL; whitelock J; LORD M, 2016, 'Chitosan sulfate: engineering a biomimetic growth factor delivery system', in Front. Bioeng. Biotechnol., Frontiers, Vol. 4, pp. A18 - A18, presented at 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016, http://dx.doi.org/10.3389/conf.FBIOE.2016.01.01019

Lord M; Whitelock J; Cheng B; Tang F; Lyons G, 2016, 'Bioengineering of human heparin: A next generation anti-coagulant', in The FASEB Journal, Federation of American Society of Experimental Biology (FASEB), San Diego, Vol. 30, pp. 1070.5 - 1070.5, presented at Experimental Biology 2016 Meeting, San Diego, 02 April 2016 - 06 April 2016, http://dx.doi.org/10.1096/fasebj.30.1_supplement.1070.5

Lord M; chuang C; rnjak-kovacina J; cheng B; lyons G; whitelock J, 2016, 'Bioengineering proteoglycan-based matrices for blood contacting applications', in The FASEB Journal, Federation of American Society of Experimental Biology (FASEB), San Diego, Vol. 6, pp. 622.2 - 622.2, presented at Experimental Biology 2016, San Diego, 02 April 2016 - 06 April 2016

Gunatillake T; Chui A; Lord M; Whitelock J; Murthi P; Ignatovic V; Monagle P; Brennecke S; Said J, 2015, '[289-POS]: Placental heparan sulphate glycosaminoglycans in pre-eclampsia.', in Pregnancy Hypertension, Elsevier, Netherlands, Vol. 5, pp. 144, Netherlands, http://dx.doi.org/10.1016/j.preghy.2014.10.295

Whitelock J; Jung M; Cheng B; Lord M, 2014, 'Transcriptional regulation and proteolytic processing of perlecan in mast cells lead to the production of forms that contain the alpha2/beta1 integrin binding site: roles in wound healing and tissue regeneration', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, CA, San Diego, Vol. 28, presented at Experimental Biology Meeting, CA, San Diego, 26 April 2014 - 30 April 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346646701331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lord M; Day A; Youssef P; Zhuo L; Watanabe H; Caterson B; Whitelock J, 2012, 'Chondroitin sulfate-mediated stabilization of hyaluronan-rich matrices', in GLYCOBIOLOGY, OXFORD UNIV PRESS INC, CA, San Diego, Vol. 22, pp. 1627 - 1627, presented at Joint Meeting of the Society-for-Glycobiology and American-Society-for-Matrix-Biology, CA, San Diego, 11 November 2012 - 14 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310368700324&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jung M; Lord M; Cheng B; Lyons JG; Alkhouri H; Hughes JM; McCarthy S; Iozzo R; Whitelock J, 2012, 'Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: A role in angiogenesis and wound healing', in GLYCOBIOLOGY, OXFORD UNIV PRESS INC, CA, San Diego, Vol. 22, pp. 1627 - 1628, presented at Joint Meeting of the Society-for-Glycobiology and American-Society-for-Matrix-Biology, CA, San Diego, 11 November 2012 - 14 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310368700326&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Whitelock JM; Jung MS; Chuang CY; Cheng B; Koo T; Lyons JG; Lord MS, 2012, 'Shorter forms of the proteoglycan, Perlecan; Adding complexity to an already complex molecule', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, CA, San Diego, Vol. 26, presented at Experimental Biology Meeting, CA, San Diego, 21 April 2012 - 25 April 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310711305959&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Penm S; Lord MS; O'Grady R; Whitelock J, 2012, 'Expression of matrix components in liver cells: Studies in human hepatocytes (HepG2) and hepatic stellate cells (LX-2)', in Glycobiology, Vol. 22, pp. 1546 - 1547, http://dx.doi.org/10.1093/glycob/cws127

Tang F; Lord M; Whitelock J, (ed.), 2012, 'The roles of melanoma-associated protein (CSPG4) and perlecan (HSPG2) in cancer, potential targets for drug therapy', in Glycobiology, Vol. 22, pp. 1605 - 1605

Lord M; Ma J; Davies N; Chuang C; Nielsen N; Iozzo R; Whitelock J, 2008, 'Modulation of biosignalling using recombinant heparan sulfate', in 8th World Biomaterials Congress 2008, Vol. 3, pp. 1237

Preprints

Chen K; Yong J; Zauner R; Wally V; Whitelock J; Sajinovic M; Kopecki Z; Liang K; Scott K; Mellick AS, 2022, Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma, , http://dx.doi.org/10.20944/preprints202211.0160.v1

Back to profile page